Genetic control of visceral leishmaniasis in a Sudanese population: Candidate gene testing indicates a linkage to the NRAMP1 region

Genes and Immunity

Volumn 4, Issue 2, 2003, Pages 104-109

  Bucheton, B ^a   Abel, L ^b   Kheir, M M ^c   Mirgani, A ^d   El Safi, S H ^c   Chevillard, C ^a   Dessein, Alain ^a  

^a Aix Marseille university   (France)

^b INSERM   (France)

^c UNIVERSITY OF KHARTOUM   (Sudan)

^d UNIVERSITY OF GEZIRA   (Sudan)

Author keywords

Human genetics; NRAMP1; Visceral leishmaniasis

Indexed keywords

CHROMOSOME 12Q; CHROMOSOME 2Q; CHROMOSOME 5Q; CHROMOSOME 6P; CHROMOSOME 6Q; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; EPIDEMIC; EVIDENCE BASED MEDICINE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENE LOCUS; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC REGULATION; GENETIC VARIABILITY; HEREDITY; HUMAN; INFECTION CONTROL; INFECTION SENSITIVITY; LEISHMANIA DONOVANI; LINKAGE ANALYSIS; MOUSE; NONHUMAN; PARASITOSIS; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; SUDAN; VISCERAL LEISHMANIASIS; ADOLESCENT; ADULT; ARTICLE; CHILD; GENETIC PREDISPOSITION; GENETICS; MALE;

LEISHMANIA DONOVANI;

CATION TRANSPORT PROTEIN; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1; NATURAL RESISTANCE-ASSOCIATED MACROPHAGE PROTEIN 1;

ADOLESCENT; ADULT; CATION TRANSPORT PROTEINS; CHILD; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEISHMANIASIS, VISCERAL; LINKAGE (GENETICS); MALE; POLYMORPHISM, GENETIC; SUDAN;

EID: 0141799481     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6363927     Document Type: Review

References (47)

1. Abel L, Dessein AJ. The impact of host genetics on susceptibility to human infectious diseases. Curr Opin Immunol 1997; 9: 509-516.
2. Lainson R, Shaw JJ, Silveira Fr. Dermal and visceral leishmaniasis and their causative agents. Trans R Soc Trop Med Hyg 1987; 81: 702-703.
3. Zijlstra EE, el-Hassan AM, Ismael A, Ghalib HW. Endemic kala-azar in eastern Sudan: a longitudinal study on the incidence of clinical and subclinical infection and post-kala-azar dermal leishmaniasis. Am J Trop Med Hyg 1994; 51: 826-836.
4. Desjeux P. The increase in risk factors for leishmaniasis worldwide. Trans R Soc Trop Med Hyg 2001; 95: 239-243.
5. Blackwell JM. Genetic susceptibility to leishmanial infections: studies in mice and man. Parasitology 1996; 112: S67-S74.
6. Gorham JD, Guler ML, Steen RG et al. Genetic mapping of a murine locus controlling development of T helper 1/T helper 2 type responses. Proc Natl Acad Sci USA 1996; 93: 12 467-12 472.
7. Vidal S, Tremblay ML, Govoni G et al. The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene. J Exp Med 1995; 182: 655-666.
8. Plant J, Glynn AA. Genetics of resistance to infection with Salmonella typhimurium in mice. J Infect Dis 1976; 133: 72-78.
9. Gros P, Skamene E, Forget A. Genetic control of natural resistance to Mycobacterium bovis (BCG) in mice. J Immunol 1981; 127: 2417-2421.
10. Skamene E, Gros P, Forget A, Patel PJ, Nesbitt MN. Regulation of resistance to leprosy by chromosome 1 locus in the mouse. Immunogenetics 1984; 19: 117-124.
11. Blackwell J, Freeman J, Bradley D. Influence of H-2 complex on acquired resistance to Leishmania donovani infection in mice. Nature 1980; 283: 72-74.
12. el-Hassan AM, Zijlstra EE, Ismael A, Ghalib HW. Recent observations on the epidemiology of kala-azar in the eastern and central states of the Sudan. Trop Geogr Med 1995; 47: 151-156.
13. Ibrahim ME, Lambson B, Yousif AO et al. Kala-azar in a high transmission focus: an ethnic and geographic dimension. Am J Trop Med Hyg 1999; 61: 941-944.
14. Shaw MA, Davies CR, Llanos-Cuentas EA, Collins A. Human genetic susceptibility and infection with Leishmania peruviana. Am J Hum Genet 1995; 57: 1159-1168.
15. Alcais A, Abel L, David C et al. Evidence for a major gene controlling susceptibility to tegumentary leishmaniasis in a recently exposed Bolivian population. Am J Hum Genet 1997; 61: 968-979.
16. Cabrera M, Shaw MA, Sharples C et al. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med 1995; 182: 1259-1264.
17. Petzl-Erler ML, Belich MP, Queiroz-Telles F. Association of mucosal leishmaniasis with HLA. Hum Immunol 1991; 32: 254-260.
18. Bucheton B, Kheir MM, El-Safi SH et al. The interplay between environmental and host factors during an outbreak of visceral leishmaniasis in eastern Sudan. Microbes Infect 2002; (in press).
19. Marquet S, Abel L, Hillaire D et al. Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33. Nat Genet 1996; 14: 181-184.
20. Garcia A, Marquet S, Bucheton B et al. Linkage analysis of blood Plasmodium falciparum levels: interest of the 5q31-q33 chromosome region. Am J Trop Med Hyg 1998; 58: 705-709.
21. Rihet P, Traore Y, Abel L et al. Malaria in humans: Plasmodium falciparum blood infection levels are linked to chromosome 5q31-q33. Am J Hum Genet 1998; 63: 498-505.
22. Meyers DA, Postma DS, Panhuysen CI et al. Evidence for a locus regulating total serum IgE levels mapping to chromosome 5. Genomics 1994; 23: 464-470.
23. Marsh DG, Neely JD, Breazeale DR et al. Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science 1994; 264: 1152-1156.
24. Heinzel FP, Sadick MD, Mutha SS, Locksley RM. Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc Natl Acad Sci USA 1991; 88: 7011-7015.
25. Casanova JL, Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol 2002; 20: 581-620.
26. Searle S, Blackwell JM. Evidence for a functional repeat polymorphism in the promoter of the human NRAMP1 gene that correlates with autoinumme versus infectious disease susceptibility. J Med Genet 1999; 36: 295-299.
27. Biggs TE, Baker ST, Botham MS et al. Nramp1 modulates iron homoeostasis in vivo and in vitro: evidence for a role in cellular iron release involving de-acidification of intracellular vesicles. Eur J Immunol 2001; 31: 2060-2070.
28. Gruenheid S, Pinner E, Desjardins M, Gros P. Natural resistance to infection with intracellular pathogens: the Nramp1 protein is recruited to the membrane of the phagosome. J Exp Med 1997; 185: 717-730.
29. Blackwell JM, Goswami T, Evans.CA et al. SLC11A1 (formerly NRAMP1) and disease resistance. Cell Microbiol 2001; 3: 773-784.
30. Bellamy R, Ruwende C, Corrah T et al. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N Engl J Med 1998; 338: 640-644.
31. Greenwood CM, Fujiwara TM, Boothroyd LJ et al. Linkage of tuberculosis to chromosome 2q35 loci, including NRAMP1, in a large aboriginal Canadian family. Am J Hum Genet 2000; 67: 405-416.
32. Abel L, Sanchez FO, Oberti J et al. Susceptibility to leprosy is linked to the human NRAMP1 gene. J Infect Dis 1998; 177: 133-145.
33. Marquet S, Sanchez FO, Arias M et al. Variants of the human NRAMP1 gene and altered human immunodeficiency virus infection susceptibility. J Infect Dis 1999; 180: 1521-1515.
34. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996; 273: 1516-1517.
35. Zijlstra EE, el-Hassan AM. Leishmaniasis in Sudan. Visceral leishmaniasis. Trans R Soc Trop Med Hyg 2001; 95 (Suppl 1): S27-S58.
36. Altare F, Jouanguy E, Lamhamedi-Cherradi S et al. A causative relationship between mutant IFNgR1 alleles, and impaired cellular response to IFNgamma in a compound heterozygous child. Am J Hum Genet 1998; 62: 723-726.
37. Gray PW, Goeddel DV. Structure of the human immune interferon gene. Nature 1982; 298: 859-863.
38. Liu J, Fujiwara TM, Buu NT et al. Identification of polymorphisms and sequence variants in the human homologue of the mouse natural resistance-associated macrophage protein gene. Am J Hum Genet 1995; 56: 845-853.
39. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: a Laboratory Manual. 2nd edn. Cold Spring Harbour Laboratory Press: New York, 1989.
40. Abel L, Alcais A, Mallet A. Comparison of four sib-pair linkage methods for analyzing sibships with more than two affecteds: interest of the binomial maximum likelihood approach. Genet Epidemiol 1998; 15: 371-390.
41. Abel L, Muller-Myhsok B. Robustness and power of the maximum-likelihood-binomial and maximum-likelihood-score methods, in multipoint linkage analysis of affected-sibship data. Am J Hum Genet 1998; 63: 638-647.
42. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES. Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet 1996; 58: 1347-1363.
43. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993; 52: 506-516.
44. Knapp M. The transmission/disequilibrium test and parental-genotype reconstruction: the reconstruction-combined transmission/disequilibrium test. Am J Hum Genet 1999; 64: 861-870.
45. Spielman RS, Ewens WJ. A sibship test for linkage in the presence of association: the sib transmission/disequilibrium test. Am J Hum Genet 1998; 62: 450-458.
46. Horvath S, Xu X, Laird NM. The family based association test method: strategies for studying general genotype-phenotype associations. Eur J Hum Genet 2001; 9: 301-306.
47. Lake SL, Blacker D, Laird NM. Family-based tests of association in the presence of linkage. Am J Hum Genet 2000; 67: 1515-1525.